# Flywire Corp: overview

FLYW · Nasdaq · CIK 1580560 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/flyw.md) · [Financials](/companies/flyw/financials.md) · [Filings](/companies/flyw/filings.md) · [Insiders](/companies/flyw/insiders.md)

Latest reported revenue: [$167.7m](/filings/0001580560-26-000016.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001580560-26-000016).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [157](/filings/0001193125-25-274358.md) | [118 d](/filings/0001193125-26-067540.md) | [133](/filings/0001580560-26-000005.md) | [132](/filings/0001580560-26-000016.md) | [200](/filings/0001193125-25-274358.md) | [158 d](/filings/0001193125-26-067540.md) | [188](/filings/0001580560-26-000005.md) | [168](/filings/0001580560-26-000016.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.9%](/filings/0001193125-25-274358.md) | [(4.9%) d](/filings/0001193125-26-067540.md) | [(8.2%)](/filings/0001580560-26-000005.md) | [(6.8%)](/filings/0001580560-26-000016.md) | [16.1%](/filings/0001193125-25-274358.md) | [(0.6%) d](/filings/0001193125-26-067540.md) | [5.7%](/filings/0001580560-26-000005.md) | [(1.7%)](/filings/0001580560-26-000016.md) |
| Net margin | % | [24.8%](/filings/0001193125-25-274358.md) | [(13.5%) d](/filings/0001193125-26-067540.md) | [(3.1%)](/filings/0001580560-26-000005.md) | [(9.1%)](/filings/0001580560-26-000016.md) | [14.8%](/filings/0001193125-25-274358.md) | [0.0% d](/filings/0001193125-26-067540.md) | [6.7%](/filings/0001580560-26-000005.md) | [(4.9%)](/filings/0001580560-26-000016.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001193125-25-274358.md) | not reported | [(0.03)](/filings/0001580560-26-000005.md) | [(0.10)](/filings/0001580560-26-000016.md) | [0.23](/filings/0001193125-25-274358.md) | not reported | [0.10](/filings/0001580560-26-000005.md) | [(0.07)](/filings/0001580560-26-000016.md) |
| Free cash flow | $m | [184 d](/filings/0001193125-25-274358.md) | [(28.7) d](/filings/0001193125-26-067540.md) | [(81.0)](/filings/0001580560-26-000005.md) | [19.4 d](/filings/0001580560-26-000016.md) | [156 d](/filings/0001193125-25-274358.md) | [4.5 d](/filings/0001193125-26-067540.md) | [(16.0)](/filings/0001580560-26-000005.md) | [20.8 d](/filings/0001580560-26-000016.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [201](/filings/0000950170-24-021713.md) | [289](/filings/0000950170-25-027078.md) | [403](/filings/0001193125-26-067540.md) | [492](/filings/0001193125-26-067540.md) | [623](/filings/0001193125-26-067540.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(6.6%)](/filings/0000950170-24-021713.md) | [(10.4%)](/filings/0000950170-25-027078.md) | [(5.3%)](/filings/0001193125-26-067540.md) | [(1.5%)](/filings/0001193125-26-067540.md) | [1.8%](/filings/0001193125-26-067540.md) |
| Net margin | % | [(14.0%)](/filings/0000950170-24-021713.md) | [(13.6%)](/filings/0000950170-25-027078.md) | [(2.1%)](/filings/0001193125-26-067540.md) | [0.6%](/filings/0001193125-26-067540.md) | [2.2%](/filings/0001193125-26-067540.md) |
| Diluted EPS | $ per share | [(0.39)](/filings/0000950170-24-021713.md) | [(0.36)](/filings/0000950170-25-027078.md) | [(0.07)](/filings/0001193125-26-067540.md) | [0.02](/filings/0001193125-26-067540.md) | [0.11](/filings/0001193125-26-067540.md) |
| Free cash flow | $m | [16.1](/filings/0000950170-24-021713.md) | [4.1](/filings/0000950170-25-027078.md) | [75.3](/filings/0001193125-26-067540.md) | [97.7](/filings/0001193125-26-067540.md) | [98.8](/filings/0001193125-26-067540.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/flyw/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2022-12-13 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 166,095 | $23.02 | $3.8m | [Form 4](/filings/0001209191-22-061240.md) |
| 2022-12-12 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 147,816 | $22.20 | $3.3m | [Form 4](/filings/0001209191-22-061240.md) |
| 2022-12-09 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 65,918 | $21.21 | $1.4m | [Form 4](/filings/0001209191-22-060726.md) |
| 2022-12-08 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 92,320 | $21.37 | $2.0m | [Form 4](/filings/0001209191-22-060726.md) |
| 2022-12-07 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 70,262 | $21.12 | $1.5m | [Form 4](/filings/0001209191-22-060404.md) |
| 2022-12-06 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 506,359 | $21.15 | $10.7m | [Form 4](/filings/0001209191-22-060404.md) |
| 2022-12-05 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 83,628 | $21.91 | $1.8m | [Form 4](/filings/0001209191-22-060002.md) |
| 2022-12-02 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 70,938 | $21.83 | $1.5m | [Form 4](/filings/0001209191-22-060002.md) |
| 2022-12-01 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 55,523 | $21.62 | $1.2m | [Form 4](/filings/0001209191-22-059414.md) |
| 2022-11-30 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 120,500 | $21.18 | $2.6m | [Form 4](/filings/0001209191-22-059414.md) |
| 2022-11-29 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 51,929 | $20.50 | $1.1m | [Form 4](/filings/0001209191-22-059009.md) |
| 2022-11-28 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 22,644 | $20.52 | $464.7k | [Form 4](/filings/0001209191-22-059009.md) |
| 2022-11-25 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 26,883 | $20.92 | $562.4k | [Form 4](/filings/0001209191-22-058829.md) |
| 2022-11-23 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 129,985 | $20.72 | $2.7m | [Form 4](/filings/0001209191-22-058829.md) |
| 2022-11-22 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 66,893 | $20.10 | $1.3m | [Form 4](/filings/0001209191-22-058590.md) |
| 2022-11-21 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 81,229 | $20.49 | $1.7m | [Form 4](/filings/0001209191-22-058590.md) |
| 2022-11-18 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 129,393 | $20.94 | $2.7m | [Form 4](/filings/0001209191-22-058255.md) |
| 2022-11-17 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 153,904 | $20.91 | $3.2m | [Form 4](/filings/0001209191-22-058255.md) |
| 2022-11-16 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 84,024 | $22.53 | $1.9m | [Form 4](/filings/0001209191-22-057598.md) |
| 2022-11-15 | [Goldman Sachs Group Inc](/insiders/886982.md) | Director | Sale (S) | 236,105 | $23.85 | $5.6m | [Form 4](/filings/0001209191-22-057598.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Voss Capital, LP](/funds/1730145.md) | 2026-06-30 | $239.5m | 13,629,500 |  | Added +4,500 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $160.7m | 9,144,416 |  | Added +480,397 |
| [Divisadero Street Capital Management, LP](/funds/1901865.md) | 2026-06-30 | $116.7m | 6,644,513 |  | Added +573,919 |
| [Temasek Holdings (Private) Ltd](/funds/1021944.md) | 2026-06-30 | $108.5m | 6,173,385 |  | Unchanged |
| [CADIAN CAPITAL MANAGEMENT, LP](/funds/1423686.md) | 2026-06-30 | $100.9m | 5,744,166 |  | Reduced −873,953 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $93.8m | 5,340,579 |  | Added +64,998 |
| [JENNISON ASSOCIATES LLC](/funds/53417.md) | 2026-06-30 | $92.6m | 5,272,962 |  | Reduced −25,919 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $87.3m | 4,966,384 |  | Reduced −10,176 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $87.2m | 4,960,457 |  | Reduced −83,708 |
| [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $79.2m | 4,506,928 |  | New +4,506,928 |

## Recent filings

[All 740 filings](/companies/flyw/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 16:04 ET | [8-K](/filings/0001628280-26-063211.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-063211 |
| 2026-08-05 | 16:03 ET | [10-Q](/filings/0001580560-26-000016.md) | Quarterly report, period 2026-06-30 | 0001580560-26-000016 |
| 2026-08-04 | 16:03 ET | [8-K](/filings/0001580560-26-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580560-26-000013 |
| 2026-06-05 | 16:02 ET | [8-K](/filings/0001580560-26-000009.md) | 5.07 Shareholder vote results | 0001580560-26-000009 |
| 2026-05-15 | 09:03 ET | [8-K](/filings/0001580560-26-000007.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001580560-26-000007 |
| 2026-05-06 | 17:36 ET | [10-Q](/filings/0001580560-26-000005.md) | Quarterly report, period 2026-03-31 | 0001580560-26-000005 |
| 2026-05-05 | 16:02 ET | [8-K](/filings/0001580560-26-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580560-26-000003 |
| 2026-04-23 | 16:26 ET | [DEF 14A](/filings/0001193125-26-173788.md) | Proxy statement, period 2026-06-02 | 0001193125-26-173788 |
| 2026-03-26 | 09:15 ET | [8-K](/filings/0001193125-26-125260.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-125260 |
| 2026-02-24 | 17:21 ET | [10-K](/filings/0001193125-26-067540.md) | Annual report, period 2025-12-31 | 0001193125-26-067540 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-067540.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f010e2da-ebaf-4155-906a-791828c57917)

## About the filer

- CIK: 1580560
- Tickers: FLYW
- Exchange: Nasdaq
- SIC code: 7389 Services-Business Services, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:45 ET. No prices; not investment advice.